Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study-Reference-Cited by-同舟云学术

Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study

Published:2018-01 Issue: Volume:88 Page:10-20
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Musolino A.^ORCID,Falcini F.,Sikokis A.,Boggiani D.,Rimanti A.,Pellegrino B.,Silini E.M.,Campanini N.,Barbieri E.,Zamagni C.,Degli Esposti R.,Cortesi L.,Bisagni G.,Cavanna L.,Frassoldati A.,Sgargi P.,Michiara M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Screening for breast cancer: an update for the U.S. preventive services task force;Nelson;Ann Intern Med,2009

2. Screening for breast cancer: U.S. preventive services task force recommendation statement;U.S. Preventive Services Task Force;Ann Intern Med,2009

3. Integrating self-referral for mammography into organised screening: results from an Italian experience;Bucchi;J Med Screen,2003

4. Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study;Gori;BMC Cancer,2012

5. Endocrine sensitivity is decisive for patient outcome in small node negative breast cancers (BC) (pT1a,b) – results from the Munich Cancer Registry;Kolben;Breast,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple metastases of human epidermal growth factor receptor 2‑positive, hormone receptor‑positive, pT1a pN0 breast cancer within 1 year after surgery: A case report;Oncology Letters;2024-06-12

2. Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2023-04